Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Opsporing en aanpak van virale en andere leverpathologie
jul 2021 | Hepatitis, Hepatologie